Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1291.3000
40.70
(
3.25
%)
NSE
Sep 09, 2025
15:31 PM
26.60% Gain from 52W Low
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
01 Jan 2022
US FDA Observation
1291.30
3.25%
Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Sharekhan
Target: 5900
Sharekhan
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - September 9, 2025
The Baseline |
09 Sep 2025, 05:38PM
Market closes higher, Waaree Renewable bags a Rs 1,252 crore solar project
Trendlyne Marketwatch |
09 Sep 2025, 04:00PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021